Yaqi Zhou

1.6k total citations
44 papers, 651 citations indexed

About

Yaqi Zhou is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Yaqi Zhou has authored 44 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Physiology and 7 papers in Cancer Research. Recurrent topics in Yaqi Zhou's work include Adenosine and Purinergic Signaling (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Immune cells in cancer (4 papers). Yaqi Zhou is often cited by papers focused on Adenosine and Purinergic Signaling (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Immune cells in cancer (4 papers). Yaqi Zhou collaborates with scholars based in China, United States and Hong Kong. Yaqi Zhou's co-authors include Qiuhua Yang, Zhiping Liu, Yuqing Huo, Mei Hong, Jiean Xu, Xiaoxiao Mao, Qian Ma, Xianqiu Zeng, David Fulton and Yapeng Cao and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Yaqi Zhou

36 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaqi Zhou China 15 294 116 107 74 72 44 651
Takhellambam S. Devi United States 11 561 1.9× 71 0.6× 59 0.6× 48 0.6× 98 1.4× 13 863
Qian Ma China 15 274 0.9× 188 1.6× 85 0.8× 19 0.3× 119 1.7× 40 726
Shicheng Yu China 16 326 1.1× 58 0.5× 170 1.6× 132 1.8× 32 0.4× 59 690
Chi Liu China 15 411 1.4× 163 1.4× 100 0.9× 17 0.2× 56 0.8× 39 834
Tongju Guan United States 11 319 1.1× 77 0.7× 76 0.7× 30 0.4× 180 2.5× 19 571
Yan Long China 17 287 1.0× 59 0.5× 92 0.9× 26 0.4× 72 1.0× 33 720
Simona‐Adriana Manea Romania 13 275 0.9× 215 1.9× 49 0.5× 37 0.5× 47 0.7× 24 637
Fabiola A. Sánchez United States 17 335 1.1× 180 1.6× 107 1.0× 35 0.5× 38 0.5× 26 841
Yanlin Zhang China 16 268 0.9× 127 1.1× 120 1.1× 27 0.4× 320 4.4× 45 754
Stephen Haigh United States 11 243 0.8× 147 1.3× 53 0.5× 18 0.2× 69 1.0× 22 631

Countries citing papers authored by Yaqi Zhou

Since Specialization
Citations

This map shows the geographic impact of Yaqi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaqi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaqi Zhou more than expected).

Fields of papers citing papers by Yaqi Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaqi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaqi Zhou. The network helps show where Yaqi Zhou may publish in the future.

Co-authorship network of co-authors of Yaqi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yaqi Zhou. A scholar is included among the top collaborators of Yaqi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaqi Zhou. Yaqi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yaqi, Dingwei Zhao, Qian Ma, et al.. (2025). Endothelial adenosine receptor 2A loss alleviates diabetic vascular calcification by blocking CREB1-SNAI1-driven EndMT. Pharmacological Research. 221. 107981–107981.
2.
Zhou, Yaqi, Dingwei Zhao, Qian Ma, et al.. (2025). Targeting adenosine 2A receptor signaling suppresses vascular calcification by restraining smooth muscle osteogenic differentiation. Pharmacological Research. 221. 108012–108012.
3.
Zhou, Yaqi, Dongyuan Wang, Jingwen Xu, & Nan Zheng. (2025). Strategic applications of methylene thioacetal bonds as disulfide surrogates in peptide drug discovery. Frontiers in Chemistry. 13. 1637329–1637329. 1 indexed citations
4.
Yang, Qiuhua, Qian Ma, Zhidan Zhang, et al.. (2024). Inactivation of adenosine receptor 2A suppresses endothelial-to-mesenchymal transition and inhibits subretinal fibrosis in mice. Science Translational Medicine. 16(737). eadk3868–eadk3868. 9 indexed citations
5.
Zhou, Yaqi, Qiuhua Yang, Jiean Xu, et al.. (2024). Blockade of endothelial adenosine receptor 2 A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition. Pharmacological Research. 203. 107156–107156. 10 indexed citations
7.
Lu, Xiaochan, et al.. (2024). Mangiferin alleviates cisplatin-induced ototoxicity in sensorineural hearing loss. Biomedicine & Pharmacotherapy. 178. 117174–117174. 9 indexed citations
8.
Du, Changjian, et al.. (2023). Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer. BMC Genomics. 24(1). 1 indexed citations
9.
Zhou, Yaqi, et al.. (2023). Ulcerative colitis and thrombocytosis: Case report and literature review. Medicine. 102(20). e33784–e33784.
10.
Zhou, Yaqi, Jie Ma, Sanyang Han, et al.. (2023). Single‐cell analysis reveals the multiple patterns of immune escape in the nasopharyngeal carcinoma microenvironment. Clinical and Translational Medicine. 13(6). e1315–e1315. 7 indexed citations
11.
Su, Xi, Dong Chen, Jia Hao, et al.. (2022). SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition. Cell Death and Disease. 13(3). 218–218. 12 indexed citations
12.
Liu, Zhiping, Huidong Shi, Jiean Xu, et al.. (2022). Single-cell transcriptome analyses reveal microglia types associated with proliferative retinopathy. JCI Insight. 7(23). 36 indexed citations
13.
Su, Xi, Peng Li, Bin Han, et al.. (2021). Vitamin C sensitizes BRAFV600E thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK/ERK signal by PLX4032. Journal of Experimental & Clinical Cancer Research. 40(1). 34–34. 22 indexed citations
14.
Zhou, Yaqi, et al.. (2021). Transcriptomic Analyses Reveal Gene Expression Profiles and Networks in Nasopharyngeal Carcinoma. BioMed Research International. 2021(1). 8890176–8890176. 2 indexed citations
15.
Xu, Jiean, Lina Wang, Qiuhua Yang, et al.. (2021). Deficiency of Myeloid Pfkfb3 Protects Mice From Lung Edema and Cardiac Dysfunction in LPS-Induced Endotoxemia. Frontiers in Cardiovascular Medicine. 8. 745810–745810. 14 indexed citations
16.
Yang, Qiuhua, Qian Ma, Jiean Xu, et al.. (2021). Prkaa1 Metabolically Regulates Monocyte/Macrophage Recruitment and Viability in Diet-Induced Murine Metabolic Disorders. Frontiers in Cell and Developmental Biology. 8. 611354–611354. 8 indexed citations
17.
Yang, Weiqiang, Yaqi Zhou, Wenbin Lei, et al.. (2020). Risk factors and survival outcomes of laryngeal squamous cell carcinoma patients with lung metastasis: A population-based study. Auris Nasus Larynx. 48(4). 723–730. 2 indexed citations
18.
19.
Wang, Lina, Yapeng Cao, Boris Gorshkov, et al.. (2019). Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia. Pharmacological Research. 146. 104292–104292. 114 indexed citations
20.
Xu, Yiming, Yong Wang, Siyuan Yan, et al.. (2017). Regulation of endothelial intracellular adenosine via adenosine kinase epigenetically modulates vascular inflammation. Nature Communications. 8(1). 943–943. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026